These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8625645)

  • 41. Early systemic hypotension and vasopressor support in low birth weight infants: impact on neurodevelopment.
    Pellicer A; Bravo MC; Madero R; Salas S; Quero J; Cabañas F
    Pediatrics; 2009 May; 123(5):1369-76. PubMed ID: 19403504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents.
    Noori S; Seri I
    Clin Perinatol; 2012 Mar; 39(1):221-38. PubMed ID: 22341548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Initial management of sepsis in the emergency room: "Time is life"].
    Soto-Torres F; Ruiz-Rodríguez DL
    Bol Asoc Med P R; 2009; 101(3):22-8. PubMed ID: 20120982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update.
    Hollenberg SM; Ahrens TS; Annane D; Astiz ME; Chalfin DB; Dasta JF; Heard SO; Martin C; Napolitano LM; Susla GM; Totaro R; Vincent JL; Zanotti-Cavazzoni S
    Crit Care Med; 2004 Sep; 32(9):1928-48. PubMed ID: 15343024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inotropes in the hypoplastic left heart syndrome: effects in an animal model.
    Riordan CJ; Randsbaek F; Storey JH; Montgomery WD; Santamore WP; Austin EH
    Ann Thorac Surg; 1996 Jul; 62(1):83-90. PubMed ID: 8678690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inotrope and vasopressor therapy of septic shock.
    Hollenberg SM
    Crit Care Clin; 2009 Oct; 25(4):781-802, ix. PubMed ID: 19892253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of vasoactive drugs on gastric intramucosal pH.
    Silva E; DeBacker D; Créteur J; Vincent JL
    Crit Care Med; 1998 Oct; 26(10):1749-58. PubMed ID: 9781735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
    Pettilä V; Merz T; Wilkman E; Perner A; Karlsson S; Lange T; Hästbacka J; Hjortrup PB; Kuitunen A; Jakob SM; Takala J
    Trials; 2016 Aug; 17():384. PubMed ID: 27484695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The new aspects of treatment of severe sepsis and septic shock].
    Adukauskiene D; Rimdeika R; Vitkauskiene A; Pilvinis V; Cicinskaite I
    Medicina (Kaunas); 2006; 42(4):265-72. PubMed ID: 16687897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of norepinephrine on the outcome of septic shock.
    Martin C; Viviand X; Leone M; Thirion X
    Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Updates in Sepsis Resuscitation.
    Ellender T; Benzoni N
    Emerg Med Clin North Am; 2020 Nov; 38(4):807-818. PubMed ID: 32981619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
    Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
    J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of vasoactive drugs on intestinal functional capillary density in endotoxemic rats: intravital video-microscopy analysis.
    Nacul FE; Guia IL; Lessa MA; Tibiriçá E
    Anesth Analg; 2010 Feb; 110(2):547-54. PubMed ID: 20081137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasoactive substances and their effects on nutrition in the critically ill patient.
    Allen JM
    Nutr Clin Pract; 2012 Jun; 27(3):335-9. PubMed ID: 22504108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasopressors for hypotensive shock.
    Havel C; Arrich J; Losert H; Gamper G; Müllner M; Herkner H
    Cochrane Database Syst Rev; 2011 May; (5):CD003709. PubMed ID: 21563137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
    Hu K; Mathew R
    Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasopressor dose equivalence: A scoping review and suggested formula.
    Goradia S; Sardaneh AA; Narayan SW; Penm J; Patanwala AE
    J Crit Care; 2021 Feb; 61():233-240. PubMed ID: 33220576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis.
    Krejci V; Hiltebrand LB; Sigurdsson GH
    Crit Care Med; 2006 May; 34(5):1456-63. PubMed ID: 16557162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sepsis: Current Definition, Pathophysiology, Diagnosis, and Management.
    Taeb AM; Hooper MH; Marik PE
    Nutr Clin Pract; 2017 Jun; 32(3):296-308. PubMed ID: 28537517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inotropes and vasopressors in adults and foals.
    Corley KT
    Vet Clin North Am Equine Pract; 2004 Apr; 20(1):77-106. PubMed ID: 15062460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.